Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 502

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 502
---
 development activities for the Company in accordance with the license agreements with TDT and the annual fee paid to TDT and are recorded as research and development expenses as incurred (see Note 3). Comprehensive Loss Comprehensive loss is equal to net loss as presented in the condensed statements of operations for the nine months ended September 30, 2024 and 2023. Net Loss per Member Unit The Company calculates basic and diluted net loss per member unit in accordance with the two-class method required for participating securities. The Company has two classes of member units, which are referred to as Class A member units and Class B member units. Class B member units are allocated 51% of earnings and losses, and Class A member units are allocated 49% of earnings and losses. The two-class method requires net loss for the period to be allocated between the member units. Basic net loss per member unit is computed by dividing net loss by the weighted-average number of member units outstanding during the period. Diluted net loss per member unit excludes the potential impact of the Company’s warrants and options because their effect would be anti-dilutive due to the Company’s net loss for the periods presented. Since the Company had a net loss in the periods presented, basic and diluted net loss per member unit is the same. The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per member unit for each class of member units (in thousands, except member unit and per member unit information):

| ​                                                   
 ​                                                   
 ​                                                   
 Basic and diluted net loss per member unit:         
 Numerator:                                          | ​ 
 ​ 
 ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ | For the nine months ended September 30, 
 2024                                    
 Class A                                 
 ​                                       
 ​                                       | ​ 
 ​ |          ​ 
          ​ | ​ 
 ​ | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | Class B 
 ​       
 ​       | ​ 
 ​ |          ​ 
          ​ | ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ | 2023    
 Class A 
 ​       
 ​       | ​ 
 ​ |          ​ 
          ​ | ​ 
 ​ | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | Class B 
 ​       
 ​       | ​ 
 ​ |          ​ 
          ​ | ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ |
|:----------------------------------------------------|:--|: